We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MH:NYSEMcGraw Hill, Inc. analysis

Data as of Sep 16, 2026 - not real-time

Latest price
$13.17
Risk: high
8/10High risk

Summary

At $13.17, McGraw Hill, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 13.9%. With RSI at 57.1 the momentum picture is neutral, alongside a bearish MACD signal. Watch $11.99 as support and $13.89 as the nearer resistance level.
On valuation the read is fair — an earnings multiple of 26.9, absent a reliable peer benchmark. The average analyst target implies 36.0% above today's level. Revenue is growing at 2.6% on a 4.4% profit margin.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 61.5%, a beta of 0.25 and a maximum drawdown of 49.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top market events

  • McGraw Hill, Inc. MH came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.48...
  • COLUMBUS, Ohio, August 17, 2026--McGraw Hill, Inc.
  • Yahoo Finance1monMcGraw Hill, Inc. to Participate in an Investor Call Hosted by Goldman SachsThe above button links to...

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading above the 200-day average of 13.12
  • MACD momentum is negative
  • 30-day price change of +13.9%

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading above the 200-day average of 13.12
  • Analyst targets imply +36.0% versus the current price
  • 30-day volatility of 61.5%

Long term

> 3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Analyst targets imply +36.0% versus the current price
  • P/E ratio of 26.9
  • Return on equity of 17.3%

Key metrics

Financial health

Revenue Growth2.60%
Profit Margin4.38%
P/E Ratio26.9
ROE17.30%
ROA3.90%
Debt/Equity336.61
P/B Ratio3.2
Op. Cash Flow$428.4M
Free Cash Flow$435.6M

Technical analysis

TrendNeutral
RSI57.1
Support$11.99
Resistance$13.89
MA 20$13.01
MA 50$11.73
MA 200$13.12
MACDBearish
VolumeDecreasing
Fear & Greed Index91.43

Valuation

Fair Value$18.52
Target Price$17.92
Upside/Downside36.04%
GradeFair
TypeBlend

Risk assessment

Beta0.25
Volatility61.51%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.